Fundraising FoxValidose
Brooklyn, US · Delaware corporation
Find your way into Validose
Sign up to see every warm intro you have to Validose
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Validose team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
10XBeta Venture Studio operates as a venture studio that invests in and supports healthcare startups developing connected medical devices, offering co-investment opportunities backed by expertise in product development, commercialization, and manufacturing.
Founders & leadership
PM
Paul McGrathChief Executive OfficerPaul McGrath led global portfolio and transformation initiatives at Pfizer and GSK focused on business scaling and operating model improvement. He is CEO of Validose, which develops real-time monitoring systems for tracking patient treatment behavior in clinical trials and remote care settings.
Board
WR
William RutanBoard director
MK
Matthew KruegerBoard director
MB
Marcel BothaCEO
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2024
▶$1.6MraisedJan 2025 · 2 investors · Other TechnologyRule 506(b)
▶$1.6MraisedJan 2025 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William RutanDirector
- Matthew KruegerDirector
- Paul McGrathExecutive Officer
- Marcel BothaDirector
- Offering amount
- $2M
- Amount sold
- $1.6M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
10x Founders10x Founders is an early-stage venture investor operating an international network of entrepreneurs and investors, primarily across Europe and the US. The firm backs early-stage startups, with its six partners having been early investors in companies such as Adyen, EquipmentShare, and Luminar.
10x Genomics10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
10x Science10x Science provides an AI platform that automates protein characterization for drug developers, reducing months of manual analysis to speed the evaluation of therapeutic candidates in early-stage development.
10x Banking10x Banking builds a cloud-native core banking platform (metacore) that lets retail, SME, and corporate/commercial banks configure and code hyper-personalized products for full core banking transformation. The company operates a SaaS platform used by banks including Chase UK, Old Mutual, West Brom Building Society, and Westpac.
Companies working in the same space as Validose.
Frequently asked questions
- What does Validose do?
- 10XBeta Venture Studio operates as a venture studio that invests in and supports healthcare startups developing connected medical devices, offering co-investment opportunities backed by expertise in product development, commercialization, and manufacturing.
- How much funding has Validose raised?
- Validose has disclosed $1.6M raised across 1 round.
- Where is Validose headquartered?
- Validose is headquartered in Brooklyn, US.